Cargando…

Advances in medicine and biology. Volume 43 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Berhardt, Leon V.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, ©2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn835646204
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 130404s2012 nyu o 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d E7B  |d OCLCF  |d EBLCP  |d OCLCQ  |d D6H  |d VTS  |d TOF  |d AU@  |d STF  |d OCLCQ  |d K6U  |d OCLCQ  |d OCLCO  |d OCLCQ 
020 |a 9781621008897  |q (electronic bk.) 
020 |a 1621008894  |q (electronic bk.) 
029 1 |a DEBBG  |b BV041049540 
029 1 |a DEBBG  |b BV043775653 
029 1 |a DEBSZ  |b 472781405 
035 |a (OCoLC)835646204 
050 4 |a R850 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616  |2 23 
049 |a UAMI 
245 0 0 |a Advances in medicine and biology.  |n Volume 43 /  |c Leon V. Berhardt, editor. 
260 |a New York :  |b Nova Science Publishers,  |c ©2012. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Includes index. 
588 0 |a Title page of PDF version (Ebsco; viewed on April 4, 2013). 
505 0 |a ADVANCES IN MEDICINE AND BIOLOGY VOLUME 43; ADVANCES IN MEDICINE AND BIOLOGY VOLUME 43; Contents ; Preface ; Paralysis in ALS Patients Pathogenesis, Assessment and Treatment ; Abstract; Introduction ; Epidemiology ; Sporadic ALS ; Familial ALS ; Etiopathogenesis ; Genetic Factors ; Environmental Factors ; Excitotoxicity ; Oxidative Stress and Apoptosis ; Lack of Neurotrophic Factors ; Immune Events and Neuroinflammation ; Defective Autophagy ; Exogenous Toxicity ; Neuropathology ; Brain ; Brainstem ; Corticospinal Tract ; Spinal Cord ; Peripheral Nervous System; Muscle; Clinical Signs. 
505 8 |a Clinical Features of Variant Disorders Diagnosis ; Clinical Criteria ; Neurophysiological Methods ; Conventional Electromyography ; Nerve Conduction Studies ; Transcranial Magnetic Stimulation ; Neuroimaging Techniques ; Laboratory Exams ; Muscle biopsy ; Biochemical Assays ; Differential Diagnoses ; Functional Assessment; Global Functional Scales ; The Appel ALS Rating Scale ; The ALS Severity Scale (ALSSS) ; ALS Functional Rating Scale ; Somatic Muscle Strength Assessment ; Manual Muscle Testing ; Maximal Voluntary Isometric Contraction ; Quantitative Electromyography. 
505 8 |a Respiratory Muscle Function Assessment Swallowing Assessment ; Speech Assessment ; Treatment; Pathogenetic Treatment ; Neuropharmacological Strategies ; Excitotoxicity ; Oxidative Stress and Apoptosis ; Neurotrophic Factors ; Neuroinflammation ; Autophagy ; Neurobiological Strategies ; Gene Therapy; Stem Cell Therapy ; Neurophysiological Strategies ; Repetitive Transcranial Magnetic Stimulation ; Symptomatic Treatment ; Pharmacological Strategies ; Non Pharmacological Strategies ; Physical Exercise ; Respiratory Treatment; Respiratory Exercises ; Mechanical Ventilation. 
505 8 |a Supportive Respiratory Care Swallowing Treatment ; Sialorrhea ; Speech Treatment ; Conclusion; References; Targeting Testosterone Pathways in Prostate Cancer Treatment ; Abstract ; Biology of Testosterone in Prostate Cancer ; 1. Androgen Synthesis and the Androgen Receptor Regulatory Pathway ; 2. Estrogen Receptors in Prostate Cancer ; 3. Prostate Cancer Prevention ; 1.) Finasteride ; 2.) Dutasteride; Androgen-Deprivation Therapy (ADT) ; 1.) Orchiectomy ; 2.) Estrogen; 3.) GnRH-A ; 4.) GnRH Antagonists ; 5.) Androgen Receptor Antagonists (ARAs) ; 6.) CYP17 Inhibitors; Ketoconazole. 
505 8 |a Abiraterone Acetate TAK-700 (Orteronel) ; 7.) AR Antagonists ; MDV3100 ; BMS-641988 ; Small Molecule Modulators ; 8.) Dual CYP17 Inhibitor and AR Antagonist ; 9.) Glucocorticoids; 2. Early-Stage Prostate Cancer ; 1.) ADT as Primary Therapy ; 2.) ADT with Radiotherapy ; 3.) ADT with Brachytherapy ; 4.) ADT with Surgery ; 3. Metastatic Castration-Sensitive Disease ; 1.) Antiandrogen Monotherapy; 2.) Combined Androgen Blockade ; 3.) ADT with Chemotherapy ; 4.) ADT and Vaccine ; 4. Timing of ADT in Metastatic Castration-Sensitive Prostate Cancer ; 1.) Immediate vs. Deferred Therapy. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Clinical medicine. 
650 0 |a Biology  |x Research. 
650 2 |a Clinical Medicine 
650 6 |a Médecine clinique. 
650 6 |a Biologie  |x Recherche. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Biology  |x Research.  |2 fast  |0 (OCoLC)fst00832448 
650 7 |a Clinical medicine.  |2 fast  |0 (OCoLC)fst00864361 
700 1 |a Berhardt, Leon V. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535147  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3021392 
938 |a ebrary  |b EBRY  |n ebr10683050 
938 |a EBSCOhost  |b EBSC  |n 535147 
938 |a YBP Library Services  |b YANK  |n 7154523 
994 |a 92  |b IZTAP